| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intestinal Mucosa | 102 | 2023 | 543 | 19.260 |
Why?
|
| Neutrophils | 63 | 2023 | 1250 | 7.720 |
Why?
|
| Colitis | 31 | 2023 | 226 | 7.450 |
Why?
|
| Hypoxia | 45 | 2023 | 1021 | 6.830 |
Why?
|
| Hypoxia-Inducible Factor 1 | 28 | 2020 | 67 | 5.540 |
Why?
|
| Epithelial Cells | 55 | 2022 | 1005 | 5.230 |
Why?
|
| Inflammation | 46 | 2023 | 2612 | 5.020 |
Why?
|
| Inflammatory Bowel Diseases | 19 | 2023 | 298 | 4.580 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 32 | 2023 | 249 | 4.500 |
Why?
|
| Colon | 18 | 2023 | 243 | 4.470 |
Why?
|
| Cell Hypoxia | 35 | 2020 | 227 | 3.950 |
Why?
|
| Adenosine | 23 | 2022 | 215 | 3.670 |
Why?
|
| Tight Junctions | 14 | 2022 | 72 | 3.580 |
Why?
|
| Butyrates | 7 | 2023 | 55 | 3.130 |
Why?
|
| Gastrointestinal Microbiome | 11 | 2023 | 557 | 3.080 |
Why?
|
| Mucous Membrane | 13 | 2023 | 123 | 2.840 |
Why?
|
| Oxygen | 18 | 2022 | 912 | 2.610 |
Why?
|
| Endothelium, Vascular | 26 | 2019 | 919 | 2.380 |
Why?
|
| Animals | 145 | 2023 | 34345 | 2.320 |
Why?
|
| Crohn Disease | 5 | 2023 | 207 | 2.320 |
Why?
|
| Signal Transduction | 42 | 2021 | 4809 | 2.290 |
Why?
|
| Intestines | 18 | 2023 | 337 | 2.160 |
Why?
|
| Homeostasis | 13 | 2021 | 605 | 2.080 |
Why?
|
| Gastrointestinal Tract | 5 | 2019 | 175 | 2.070 |
Why?
|
| Wound Healing | 6 | 2022 | 298 | 1.830 |
Why?
|
| Cell Line | 50 | 2021 | 2806 | 1.830 |
Why?
|
| Mice | 84 | 2023 | 15984 | 1.820 |
Why?
|
| Mucositis | 4 | 2023 | 20 | 1.770 |
Why?
|
| Cellular Microenvironment | 5 | 2017 | 80 | 1.730 |
Why?
|
| Immunity, Mucosal | 7 | 2017 | 86 | 1.680 |
Why?
|
| 5'-Nucleotidase | 10 | 2017 | 37 | 1.670 |
Why?
|
| Immunity, Innate | 8 | 2020 | 759 | 1.620 |
Why?
|
| Gene Expression Regulation | 27 | 2021 | 2492 | 1.580 |
Why?
|
| Receptor, Adenosine A2B | 9 | 2015 | 34 | 1.530 |
Why?
|
| Energy Metabolism | 8 | 2021 | 786 | 1.520 |
Why?
|
| Mice, Inbred C57BL | 38 | 2023 | 5102 | 1.490 |
Why?
|
| Antiporters | 2 | 2021 | 18 | 1.440 |
Why?
|
| Acidosis | 4 | 2021 | 95 | 1.420 |
Why?
|
| Interferon-gamma | 16 | 2023 | 749 | 1.410 |
Why?
|
| Eicosapentaenoic Acid | 4 | 2020 | 29 | 1.360 |
Why?
|
| Humans | 197 | 2023 | 125131 | 1.350 |
Why?
|
| Cells, Cultured | 53 | 2022 | 4159 | 1.350 |
Why?
|
| Membrane Proteins | 16 | 2020 | 1089 | 1.350 |
Why?
|
| Dextran Sulfate | 13 | 2023 | 71 | 1.240 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2021 | 207 | 1.240 |
Why?
|
| Inflammation Mediators | 7 | 2017 | 515 | 1.210 |
Why?
|
| Receptors, Interleukin-10 | 2 | 2018 | 6 | 1.210 |
Why?
|
| Nucleotides | 4 | 2018 | 119 | 1.210 |
Why?
|
| Cullin Proteins | 3 | 2014 | 12 | 1.190 |
Why?
|
| Prolyl-Hydroxylase Inhibitors | 2 | 2021 | 4 | 1.190 |
Why?
|
| Bacteria | 5 | 2021 | 767 | 1.190 |
Why?
|
| Cell Movement | 27 | 2018 | 913 | 1.180 |
Why?
|
| Dysbiosis | 2 | 2021 | 151 | 1.180 |
Why?
|
| Transcription, Genetic | 14 | 2019 | 1376 | 1.170 |
Why?
|
| Caco-2 Cells | 17 | 2020 | 68 | 1.150 |
Why?
|
| Indoles | 2 | 2021 | 327 | 1.140 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 5 | 2021 | 145 | 1.140 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2021 | 232 | 1.100 |
Why?
|
| Microfilament Proteins | 5 | 2020 | 135 | 1.100 |
Why?
|
| Fatty Acids, Volatile | 4 | 2023 | 48 | 1.060 |
Why?
|
| Mice, Knockout | 27 | 2021 | 2736 | 1.050 |
Why?
|
| Creatine | 4 | 2023 | 56 | 1.030 |
Why?
|
| Cell Adhesion Molecules | 11 | 2020 | 182 | 1.010 |
Why?
|
| Neutrophil Activation | 6 | 2019 | 100 | 1.010 |
Why?
|
| Gastrointestinal Diseases | 3 | 2019 | 194 | 1.000 |
Why?
|
| Colitis, Ulcerative | 2 | 2020 | 108 | 0.990 |
Why?
|
| Ileitis | 2 | 2023 | 26 | 0.960 |
Why?
|
| Disease Models, Animal | 25 | 2023 | 3823 | 0.960 |
Why?
|
| Leukocytes | 8 | 2018 | 292 | 0.940 |
Why?
|
| Cell Communication | 12 | 2022 | 282 | 0.930 |
Why?
|
| Transcription Factors | 10 | 2022 | 1604 | 0.890 |
Why?
|
| Chemotaxis, Leukocyte | 14 | 2012 | 134 | 0.880 |
Why?
|
| Cell Membrane Permeability | 7 | 2017 | 90 | 0.880 |
Why?
|
| Antigens, CD1 | 11 | 2004 | 59 | 0.870 |
Why?
|
| Blood Proteins | 5 | 2006 | 253 | 0.850 |
Why?
|
| Pyrophosphatases | 2 | 2018 | 22 | 0.850 |
Why?
|
| Antigens, CD | 13 | 2008 | 466 | 0.850 |
Why?
|
| Cell Adhesion | 22 | 2022 | 455 | 0.830 |
Why?
|
| Salmonella Infections | 2 | 2022 | 51 | 0.830 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 2 | 2013 | 15 | 0.830 |
Why?
|
| Endothelial Cells | 8 | 2013 | 742 | 0.810 |
Why?
|
| Oxidation-Reduction | 4 | 2021 | 943 | 0.810 |
Why?
|
| Antimicrobial Cationic Peptides | 7 | 2017 | 77 | 0.800 |
Why?
|
| Promoter Regions, Genetic | 17 | 2020 | 1195 | 0.800 |
Why?
|
| Procollagen-Proline Dioxygenase | 8 | 2011 | 25 | 0.790 |
Why?
|
| Capillary Permeability | 5 | 2009 | 148 | 0.780 |
Why?
|
| Peroxidase | 2 | 2021 | 184 | 0.780 |
Why?
|
| Diet, Paleolithic | 1 | 2021 | 3 | 0.770 |
Why?
|
| Bystander Effect | 1 | 2021 | 15 | 0.760 |
Why?
|
| Adenosine Triphosphate | 8 | 2022 | 459 | 0.760 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2021 | 19 | 0.740 |
Why?
|
| Intestinal Diseases | 2 | 2011 | 31 | 0.730 |
Why?
|
| Ubiquitins | 3 | 2014 | 34 | 0.720 |
Why?
|
| Lipopolysaccharides | 10 | 2013 | 870 | 0.720 |
Why?
|
| Immunomodulation | 2 | 2020 | 89 | 0.720 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2020 | 4 | 0.720 |
Why?
|
| Platelet Membrane Glycoproteins | 3 | 2020 | 43 | 0.710 |
Why?
|
| Tryptophan | 3 | 2023 | 147 | 0.710 |
Why?
|
| Chemokines | 4 | 2018 | 232 | 0.710 |
Why?
|
| Autophagy-Related Proteins | 1 | 2020 | 48 | 0.710 |
Why?
|
| Tumor Necrosis Factor-alpha | 12 | 2020 | 1198 | 0.690 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 2 | 2017 | 6 | 0.690 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 84 | 0.680 |
Why?
|
| Hydrogen Peroxide | 1 | 2021 | 297 | 0.670 |
Why?
|
| Creatine Kinase | 2 | 2023 | 79 | 0.670 |
Why?
|
| Phosphoproteins | 5 | 2009 | 320 | 0.670 |
Why?
|
| Bacteroides | 1 | 2019 | 18 | 0.660 |
Why?
|
| Corrinoids | 1 | 2019 | 7 | 0.660 |
Why?
|
| HeLa Cells | 11 | 2020 | 607 | 0.660 |
Why?
|
| Lipoxins | 9 | 2005 | 10 | 0.660 |
Why?
|
| Heme Oxygenase-1 | 2 | 2021 | 52 | 0.660 |
Why?
|
| Cell Cycle Proteins | 3 | 2016 | 579 | 0.650 |
Why?
|
| Membrane Transport Proteins | 1 | 2020 | 143 | 0.650 |
Why?
|
| Dietary Supplements | 2 | 2021 | 478 | 0.650 |
Why?
|
| Vitamin B Complex | 1 | 2019 | 38 | 0.650 |
Why?
|
| Interleukin-6 | 4 | 2020 | 710 | 0.630 |
Why?
|
| Polyphosphates | 1 | 2018 | 34 | 0.630 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2018 | 45 | 0.620 |
Why?
|
| Vitamin B 12 | 1 | 2019 | 116 | 0.620 |
Why?
|
| Gene Knockdown Techniques | 6 | 2020 | 317 | 0.620 |
Why?
|
| Permeability | 8 | 2022 | 155 | 0.610 |
Why?
|
| Hypoxanthine | 1 | 2018 | 11 | 0.610 |
Why?
|
| Microbiota | 3 | 2023 | 683 | 0.600 |
Why?
|
| Bacteroidaceae | 1 | 2017 | 3 | 0.590 |
Why?
|
| Citrobacter rodentium | 1 | 2017 | 6 | 0.590 |
Why?
|
| Bacteria, Anaerobic | 1 | 2017 | 20 | 0.590 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2017 | 12 | 0.590 |
Why?
|
| Oxygen Consumption | 7 | 2018 | 620 | 0.570 |
Why?
|
| Cytokines | 9 | 2023 | 1927 | 0.570 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2017 | 32 | 0.570 |
Why?
|
| Prolyl Hydroxylases | 2 | 2014 | 4 | 0.570 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2017 | 44 | 0.560 |
Why?
|
| CD55 Antigens | 4 | 2007 | 27 | 0.560 |
Why?
|
| Immunity | 1 | 2017 | 130 | 0.560 |
Why?
|
| Transendothelial and Transepithelial Migration | 5 | 2019 | 29 | 0.550 |
Why?
|
| Adaptation, Physiological | 4 | 2019 | 517 | 0.550 |
Why?
|
| Receptors, Purinergic P1 | 5 | 2011 | 26 | 0.550 |
Why?
|
| Transcriptional Activation | 10 | 2017 | 363 | 0.550 |
Why?
|
| Endopeptidases | 2 | 2014 | 73 | 0.540 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 563 | 0.540 |
Why?
|
| CD18 Antigens | 8 | 2007 | 36 | 0.530 |
Why?
|
| Alprostadil | 2 | 2013 | 38 | 0.530 |
Why?
|
| Gastroenteritis | 1 | 2017 | 66 | 0.530 |
Why?
|
| Interleukin-10 | 6 | 2017 | 311 | 0.520 |
Why?
|
| NF-kappa B | 11 | 2019 | 681 | 0.520 |
Why?
|
| Chlorides | 10 | 1998 | 138 | 0.520 |
Why?
|
| Salmonella | 1 | 2016 | 54 | 0.520 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2016 | 420 | 0.520 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 8 | 2003 | 41 | 0.510 |
Why?
|
| RNA, Messenger | 18 | 2022 | 2753 | 0.510 |
Why?
|
| Eosinophils | 6 | 2021 | 273 | 0.510 |
Why?
|
| Down-Regulation | 7 | 2017 | 652 | 0.510 |
Why?
|
| Ischemia | 4 | 2014 | 383 | 0.500 |
Why?
|
| Host-Pathogen Interactions | 4 | 2020 | 312 | 0.500 |
Why?
|
| Apyrase | 4 | 2008 | 15 | 0.500 |
Why?
|
| Cyclic AMP | 8 | 2002 | 264 | 0.500 |
Why?
|
| Intercellular Adhesion Molecule-1 | 8 | 2008 | 178 | 0.490 |
Why?
|
| DNA Primers | 8 | 2013 | 545 | 0.490 |
Why?
|
| Up-Regulation | 9 | 2019 | 895 | 0.480 |
Why?
|
| Inflammasomes | 3 | 2020 | 120 | 0.480 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 840 | 0.470 |
Why?
|
| Blood Platelets | 4 | 2008 | 397 | 0.470 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 639 | 0.470 |
Why?
|
| Mucins | 2 | 2006 | 69 | 0.460 |
Why?
|
| DNA-Binding Proteins | 8 | 2008 | 1373 | 0.450 |
Why?
|
| Cell Membrane | 10 | 2009 | 732 | 0.440 |
Why?
|
| beta-Defensins | 1 | 2013 | 22 | 0.430 |
Why?
|
| Epithelium | 21 | 2011 | 318 | 0.430 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2013 | 73 | 0.420 |
Why?
|
| Pharmaceutical Preparations | 1 | 2014 | 171 | 0.410 |
Why?
|
| Models, Biological | 10 | 2016 | 1753 | 0.410 |
Why?
|
| Acute Lung Injury | 5 | 2017 | 319 | 0.410 |
Why?
|
| Gene Expression | 9 | 2020 | 1528 | 0.410 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 299 | 0.410 |
Why?
|
| Bacterial Translocation | 1 | 2012 | 37 | 0.400 |
Why?
|
| Body Fluids | 1 | 2012 | 65 | 0.400 |
Why?
|
| Oxidative Stress | 3 | 2019 | 1210 | 0.400 |
Why?
|
| Autacoids | 1 | 2011 | 1 | 0.400 |
Why?
|
| Blotting, Western | 13 | 2016 | 1233 | 0.390 |
Why?
|
| Ileum | 2 | 2023 | 102 | 0.390 |
Why?
|
| Phosphorylation | 7 | 2021 | 1694 | 0.390 |
Why?
|
| Isoenzymes | 5 | 2009 | 311 | 0.390 |
Why?
|
| Chediak-Higashi Syndrome | 4 | 1992 | 7 | 0.390 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2022 | 562 | 0.380 |
Why?
|
| Disease Susceptibility | 4 | 2020 | 343 | 0.380 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 13 | 0.380 |
Why?
|
| Adrenomedullin | 1 | 2011 | 5 | 0.380 |
Why?
|
| Enzyme Inhibitors | 4 | 2008 | 841 | 0.380 |
Why?
|
| Metabolomics | 2 | 2018 | 551 | 0.370 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 2 | 2002 | 21 | 0.360 |
Why?
|
| Chlorine | 2 | 2012 | 62 | 0.360 |
Why?
|
| Fibrosis | 2 | 2023 | 497 | 0.350 |
Why?
|
| Salmonella enterica | 3 | 2022 | 53 | 0.350 |
Why?
|
| Adenosine Monophosphate | 5 | 2011 | 52 | 0.350 |
Why?
|
| Extracellular Matrix | 2 | 2006 | 462 | 0.350 |
Why?
|
| Tight Junction Proteins | 2 | 2020 | 9 | 0.340 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 160 | 0.340 |
Why?
|
| Gram-Positive Bacteria | 1 | 2009 | 47 | 0.340 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 4 | 2002 | 61 | 0.330 |
Why?
|
| Monocytes | 3 | 2021 | 523 | 0.330 |
Why?
|
| Paracrine Communication | 2 | 2000 | 61 | 0.330 |
Why?
|
| Multienzyme Complexes | 2 | 2000 | 65 | 0.330 |
Why?
|
| Cysteine Endopeptidases | 2 | 2000 | 61 | 0.330 |
Why?
|
| Base Sequence | 10 | 2008 | 2207 | 0.320 |
Why?
|
| Integrin beta1 | 1 | 2008 | 21 | 0.320 |
Why?
|
| Myeloid Cells | 1 | 2010 | 128 | 0.320 |
Why?
|
| Cell Line, Tumor | 8 | 2018 | 2913 | 0.320 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2012 | 1008 | 0.320 |
Why?
|
| Microcirculation | 6 | 2012 | 157 | 0.320 |
Why?
|
| Sp1 Transcription Factor | 1 | 2008 | 23 | 0.320 |
Why?
|
| Immunity, Cellular | 1 | 2010 | 277 | 0.310 |
Why?
|
| Lung | 11 | 2021 | 3865 | 0.300 |
Why?
|
| Interleukin-8 | 6 | 2005 | 254 | 0.300 |
Why?
|
| Nuclear Proteins | 5 | 2004 | 614 | 0.300 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2008 | 107 | 0.300 |
Why?
|
| Repressor Proteins | 1 | 2011 | 383 | 0.300 |
Why?
|
| Adenosine Deaminase | 2 | 2013 | 27 | 0.300 |
Why?
|
| Claudin-1 | 2 | 2019 | 23 | 0.290 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 2 | 2008 | 9 | 0.290 |
Why?
|
| Cholestasis | 2 | 2020 | 234 | 0.280 |
Why?
|
| Symbiosis | 2 | 2017 | 65 | 0.280 |
Why?
|
| STAT3 Transcription Factor | 4 | 2021 | 192 | 0.280 |
Why?
|
| Connexin 43 | 1 | 2006 | 24 | 0.280 |
Why?
|
| Cat Diseases | 3 | 1992 | 13 | 0.280 |
Why?
|
| Interferon-alpha | 1 | 2008 | 193 | 0.280 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2002 | 141 | 0.280 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 1559 | 0.270 |
Why?
|
| Umbilical Veins | 5 | 2002 | 60 | 0.270 |
Why?
|
| Salmonella typhimurium | 5 | 2018 | 177 | 0.270 |
Why?
|
| Female | 34 | 2021 | 64889 | 0.270 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2006 | 10 | 0.270 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2015 | 369 | 0.270 |
Why?
|
| Liver | 6 | 2023 | 1872 | 0.270 |
Why?
|
| Adjuvants, Immunologic | 2 | 2005 | 211 | 0.270 |
Why?
|
| Aspirin | 5 | 2007 | 348 | 0.270 |
Why?
|
| Liver Neoplasms | 2 | 2023 | 482 | 0.270 |
Why?
|
| E-Selectin | 2 | 1996 | 54 | 0.270 |
Why?
|
| Equilibrative-Nucleoside Transporter 2 | 1 | 2005 | 1 | 0.260 |
Why?
|
| Protein Stability | 3 | 2019 | 162 | 0.260 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2005 | 13 | 0.260 |
Why?
|
| Tumor Cells, Cultured | 7 | 2021 | 902 | 0.260 |
Why?
|
| Adenine Nucleotides | 2 | 2003 | 20 | 0.250 |
Why?
|
| Cholera Toxin | 1 | 2005 | 30 | 0.250 |
Why?
|
| Cell Polarity | 10 | 2013 | 131 | 0.250 |
Why?
|
| Antigen Presentation | 4 | 2003 | 194 | 0.250 |
Why?
|
| Heme | 3 | 2021 | 48 | 0.240 |
Why?
|
| Reperfusion Injury | 3 | 2021 | 284 | 0.240 |
Why?
|
| Vasodilator Agents | 2 | 2009 | 339 | 0.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2015 | 1196 | 0.240 |
Why?
|
| Intercellular Junctions | 3 | 2002 | 34 | 0.240 |
Why?
|
| Interleukin-4 | 2 | 1996 | 211 | 0.240 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2015 | 785 | 0.240 |
Why?
|
| Myocardial Ischemia | 2 | 2019 | 269 | 0.230 |
Why?
|
| Genes, MDR | 1 | 2004 | 2 | 0.230 |
Why?
|
| Eosinophilic Esophagitis | 2 | 2019 | 308 | 0.230 |
Why?
|
| NEDD8 Protein | 2 | 2014 | 2 | 0.230 |
Why?
|
| Drug Resistance, Multiple | 1 | 2004 | 19 | 0.230 |
Why?
|
| Ventilator-Induced Lung Injury | 3 | 2014 | 53 | 0.230 |
Why?
|
| Administration, Oral | 2 | 2019 | 785 | 0.220 |
Why?
|
| Actins | 3 | 2023 | 410 | 0.220 |
Why?
|
| Male | 33 | 2021 | 60792 | 0.220 |
Why?
|
| Pneumonia | 3 | 2012 | 610 | 0.220 |
Why?
|
| Carrier Proteins | 7 | 2010 | 743 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 6 | 2007 | 304 | 0.220 |
Why?
|
| Interleukin-13 | 4 | 2021 | 134 | 0.220 |
Why?
|
| Tyrosine | 2 | 2021 | 243 | 0.220 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2003 | 74 | 0.220 |
Why?
|
| Kupffer Cells | 2 | 2020 | 50 | 0.210 |
Why?
|
| RNA, Small Interfering | 4 | 2017 | 584 | 0.210 |
Why?
|
| Biological Transport | 4 | 2009 | 392 | 0.210 |
Why?
|
| Lubiprostone | 2 | 2013 | 9 | 0.210 |
Why?
|
| Kidney | 3 | 2013 | 1379 | 0.200 |
Why?
|
| Cyclooxygenase 2 | 5 | 2005 | 171 | 0.200 |
Why?
|
| Acute Disease | 3 | 2017 | 1016 | 0.200 |
Why?
|
| Arthritis, Experimental | 1 | 2023 | 130 | 0.200 |
Why?
|
| Adherens Junctions | 2 | 2017 | 28 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 3 | 2013 | 1042 | 0.200 |
Why?
|
| Receptors, Cell Surface | 3 | 2010 | 368 | 0.200 |
Why?
|
| Endotoxemia | 2 | 2013 | 94 | 0.200 |
Why?
|
| Interleukin-1 | 3 | 2022 | 984 | 0.200 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2003 | 837 | 0.190 |
Why?
|
| Response Elements | 2 | 2020 | 87 | 0.190 |
Why?
|
| Glycolysis | 2 | 2021 | 241 | 0.190 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 6 | 2006 | 68 | 0.190 |
Why?
|
| Myocardial Infarction | 2 | 2008 | 1142 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2014 | 471 | 0.190 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2021 | 13 | 0.190 |
Why?
|
| Halogenation | 1 | 2021 | 15 | 0.190 |
Why?
|
| Coculture Techniques | 4 | 2006 | 211 | 0.190 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2021 | 31 | 0.190 |
Why?
|
| Purines | 2 | 2021 | 172 | 0.190 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2013 | 8 | 0.190 |
Why?
|
| Growth Substances | 1 | 2001 | 139 | 0.190 |
Why?
|
| Interleukin-1beta | 3 | 2020 | 382 | 0.190 |
Why?
|
| Neuropeptides | 1 | 2001 | 73 | 0.180 |
Why?
|
| Receptors, Cytokine | 2 | 2016 | 34 | 0.180 |
Why?
|
| Mucoproteins | 1 | 2020 | 11 | 0.180 |
Why?
|
| Kinetics | 7 | 2005 | 1680 | 0.180 |
Why?
|
| Autocrine Communication | 2 | 2002 | 44 | 0.180 |
Why?
|
| Polysaccharide-Lyases | 1 | 2000 | 13 | 0.180 |
Why?
|
| Molecular Sequence Data | 7 | 2008 | 2926 | 0.180 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2000 | 22 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2021 | 307 | 0.180 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 2 | 2018 | 8 | 0.180 |
Why?
|
| Organoids | 1 | 2021 | 81 | 0.180 |
Why?
|
| Mammals | 1 | 2022 | 260 | 0.180 |
Why?
|
| Adenosine Diphosphate | 3 | 2011 | 90 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2021 | 199 | 0.180 |
Why?
|
| Antigens, CD1d | 8 | 2004 | 65 | 0.170 |
Why?
|
| Endotoxins | 1 | 2021 | 237 | 0.170 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2019 | 22 | 0.170 |
Why?
|
| Leukocyte Disorders | 1 | 2019 | 11 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2002 | 354 | 0.170 |
Why?
|
| Case-Control Studies | 3 | 2020 | 3326 | 0.170 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2013 | 364 | 0.170 |
Why?
|
| Flow Cytometry | 6 | 2016 | 1108 | 0.170 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2020 | 76 | 0.170 |
Why?
|
| Immune System Diseases | 1 | 2019 | 36 | 0.170 |
Why?
|
| Macrophages | 3 | 2023 | 1333 | 0.170 |
Why?
|
| Amino Acid Sequence | 5 | 2005 | 2098 | 0.170 |
Why?
|
| Phototherapy | 1 | 2019 | 27 | 0.170 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2008 | 291 | 0.170 |
Why?
|
| Protein Binding | 3 | 2013 | 2014 | 0.170 |
Why?
|
| Muscle Proteins | 1 | 2001 | 224 | 0.170 |
Why?
|
| Bile Acids and Salts | 1 | 2020 | 180 | 0.170 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 140 | 0.170 |
Why?
|
| Cecum | 1 | 2019 | 38 | 0.170 |
Why?
|
| Dogs | 3 | 2001 | 394 | 0.160 |
Why?
|
| Biopsy | 2 | 2020 | 1093 | 0.160 |
Why?
|
| Mucin-5B | 1 | 2021 | 184 | 0.160 |
Why?
|
| Circadian Clocks | 1 | 2019 | 48 | 0.160 |
Why?
|
| Receptors, Prostaglandin | 1 | 1998 | 26 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 423 | 0.160 |
Why?
|
| Dinucleoside Phosphates | 1 | 2018 | 24 | 0.160 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 1006 | 0.160 |
Why?
|
| Calcium | 3 | 2002 | 1211 | 0.160 |
Why?
|
| Dactinomycin | 1 | 2018 | 25 | 0.160 |
Why?
|
| Neutrophil Infiltration | 5 | 2012 | 100 | 0.160 |
Why?
|
| THP-1 Cells | 1 | 2018 | 24 | 0.160 |
Why?
|
| Enzyme Precursors | 2 | 2012 | 15 | 0.160 |
Why?
|
| Aldehydes | 1 | 2019 | 173 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 717 | 0.160 |
Why?
|
| Mitochondria | 2 | 2023 | 823 | 0.150 |
Why?
|
| Collagen | 4 | 2023 | 443 | 0.150 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2020 | 143 | 0.150 |
Why?
|
| Nucleotides, Cyclic | 1 | 1998 | 15 | 0.150 |
Why?
|
| Gene Expression Profiling | 5 | 2012 | 1642 | 0.150 |
Why?
|
| Binding Sites | 4 | 2021 | 1248 | 0.150 |
Why?
|
| Lipids | 1 | 2002 | 629 | 0.150 |
Why?
|
| Cell Culture Techniques | 3 | 2017 | 356 | 0.150 |
Why?
|
| Water-Electrolyte Balance | 1 | 1998 | 31 | 0.150 |
Why?
|
| Hydroxylation | 2 | 2016 | 28 | 0.150 |
Why?
|
| Guanylate Cyclase | 1 | 1998 | 37 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2015 | 415 | 0.150 |
Why?
|
| Claudin-2 | 1 | 2017 | 2 | 0.150 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1998 | 89 | 0.150 |
Why?
|
| Vascular Diseases | 1 | 2021 | 251 | 0.150 |
Why?
|
| Acetaminophen | 2 | 2020 | 262 | 0.150 |
Why?
|
| Cloning, Molecular | 2 | 2011 | 566 | 0.150 |
Why?
|
| Dextrans | 2 | 2013 | 76 | 0.150 |
Why?
|
| Claudins | 1 | 2017 | 24 | 0.150 |
Why?
|
| Adenylyl Cyclases | 1 | 1998 | 142 | 0.140 |
Why?
|
| Period Circadian Proteins | 2 | 2019 | 22 | 0.140 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2017 | 97 | 0.140 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2017 | 41 | 0.140 |
Why?
|
| Feces | 1 | 2019 | 402 | 0.140 |
Why?
|
| Dendritic Cells | 1 | 2020 | 445 | 0.140 |
Why?
|
| Pulmonary Alveoli | 2 | 2017 | 399 | 0.140 |
Why?
|
| Organ Specificity | 1 | 2017 | 288 | 0.140 |
Why?
|
| Neovascularization, Physiologic | 2 | 2009 | 189 | 0.140 |
Why?
|
| RNA Interference | 4 | 2012 | 476 | 0.140 |
Why?
|
| Respiratory Mucosa | 3 | 2012 | 264 | 0.140 |
Why?
|
| Clostridium | 1 | 2016 | 15 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2017 | 169 | 0.130 |
Why?
|
| SUMO-1 Protein | 2 | 2009 | 21 | 0.130 |
Why?
|
| Kynurenine | 1 | 2017 | 82 | 0.130 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2017 | 98 | 0.130 |
Why?
|
| Liver Diseases | 1 | 2019 | 325 | 0.130 |
Why?
|
| Leukemia | 1 | 2018 | 212 | 0.130 |
Why?
|
| Mucus | 1 | 2016 | 57 | 0.130 |
Why?
|
| Models, Animal | 2 | 2013 | 373 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 593 | 0.130 |
Why?
|
| Immune System | 1 | 2017 | 183 | 0.130 |
Why?
|
| Docosahexaenoic Acids | 2 | 2007 | 71 | 0.130 |
Why?
|
| Hypercapnia | 1 | 2016 | 56 | 0.130 |
Why?
|
| Antigens, Surface | 1 | 1996 | 159 | 0.130 |
Why?
|
| Histone Deacetylases | 1 | 2017 | 204 | 0.130 |
Why?
|
| Recombinant Proteins | 8 | 2013 | 1327 | 0.130 |
Why?
|
| Disease Management | 1 | 2020 | 599 | 0.130 |
Why?
|
| Adult | 13 | 2021 | 33167 | 0.130 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2023 | 1001 | 0.130 |
Why?
|
| Purine Nucleosides | 1 | 2015 | 3 | 0.130 |
Why?
|
| Antioxidants | 1 | 2019 | 585 | 0.130 |
Why?
|
| Esophagus | 1 | 2017 | 243 | 0.130 |
Why?
|
| Platelet Aggregation | 3 | 1992 | 99 | 0.130 |
Why?
|
| Carbohydrate Metabolism | 1 | 1995 | 50 | 0.120 |
Why?
|
| Virulence | 1 | 2016 | 251 | 0.120 |
Why?
|
| Proteasome Endopeptidase Complex | 4 | 2012 | 141 | 0.120 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 524 | 0.120 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 467 | 0.120 |
Why?
|
| Fluoresceins | 1 | 1995 | 47 | 0.120 |
Why?
|
| Stress, Mechanical | 2 | 2014 | 456 | 0.120 |
Why?
|
| Biomarkers | 3 | 2017 | 3736 | 0.120 |
Why?
|
| Cyclopentanes | 1 | 2014 | 16 | 0.120 |
Why?
|
| Metabolome | 1 | 2018 | 307 | 0.120 |
Why?
|
| Granulocytes | 2 | 2011 | 81 | 0.120 |
Why?
|
| Receptors, Lipoxin | 2 | 2005 | 2 | 0.120 |
Why?
|
| Trefoil Factor-2 | 2 | 2006 | 3 | 0.120 |
Why?
|
| Nitric Oxide | 2 | 2010 | 886 | 0.120 |
Why?
|
| Cytoplasm | 3 | 2001 | 276 | 0.120 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 194 | 0.120 |
Why?
|
| Prognosis | 2 | 2013 | 3616 | 0.120 |
Why?
|
| Pituitary Gland | 1 | 2015 | 165 | 0.120 |
Why?
|
| Carbon Dioxide | 1 | 2016 | 258 | 0.120 |
Why?
|
| Glucose | 2 | 2018 | 995 | 0.110 |
Why?
|
| NADPH Oxidase 2 | 1 | 2014 | 42 | 0.110 |
Why?
|
| Protease Inhibitors | 1 | 2014 | 107 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2014 | 132 | 0.110 |
Why?
|
| Leukemia, Promyelocytic, Acute | 2 | 1993 | 13 | 0.110 |
Why?
|
| Zonula Occludens-1 Protein | 3 | 2002 | 13 | 0.110 |
Why?
|
| Genes, Reporter | 4 | 2014 | 274 | 0.110 |
Why?
|
| Periodontitis | 2 | 2004 | 55 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 180 | 0.110 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 139 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 170 | 0.110 |
Why?
|
| Hypertension, Renal | 1 | 2013 | 28 | 0.110 |
Why?
|
| CD11 Antigens | 3 | 2007 | 32 | 0.110 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 3 | 2022 | 150 | 0.110 |
Why?
|
| Adenosine Triphosphatases | 2 | 2004 | 162 | 0.110 |
Why?
|
| Bone Marrow Transplantation | 2 | 2010 | 260 | 0.110 |
Why?
|
| Thromboxane-A Synthase | 1 | 1992 | 2 | 0.110 |
Why?
|
| Middle Aged | 7 | 2021 | 29112 | 0.110 |
Why?
|
| Sepsis | 2 | 2017 | 563 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2013 | 502 | 0.100 |
Why?
|
| Hepatocytes | 3 | 2023 | 207 | 0.100 |
Why?
|
| Macrophage-1 Antigen | 3 | 1998 | 36 | 0.100 |
Why?
|
| Mucin 5AC | 1 | 2012 | 47 | 0.100 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 1992 | 71 | 0.100 |
Why?
|
| Membrane Glycoproteins | 2 | 2014 | 454 | 0.100 |
Why?
|
| T-Lymphocytes | 4 | 2004 | 1793 | 0.100 |
Why?
|
| Disease Progression | 2 | 2011 | 2577 | 0.100 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2012 | 94 | 0.100 |
Why?
|
| Pyridones | 1 | 2013 | 120 | 0.100 |
Why?
|
| Electrolytes | 1 | 2012 | 63 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2017 | 537 | 0.100 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2006 | 306 | 0.100 |
Why?
|
| In Vitro Techniques | 7 | 2000 | 1144 | 0.100 |
Why?
|
| Chloride Channel Agonists | 1 | 2012 | 62 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2007 | 410 | 0.100 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2011 | 155 | 0.100 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2011 | 30 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2014 | 391 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 186 | 0.100 |
Why?
|
| Adenosylhomocysteinase | 1 | 2011 | 10 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2013 | 1366 | 0.100 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2011 | 10 | 0.100 |
Why?
|
| Receptors, Adrenomedullin | 1 | 2011 | 1 | 0.100 |
Why?
|
| Extracellular Space | 1 | 2011 | 132 | 0.090 |
Why?
|
| Platelet Activating Factor | 2 | 2005 | 95 | 0.090 |
Why?
|
| Metagenome | 1 | 2012 | 127 | 0.090 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 2061 | 0.090 |
Why?
|
| Cats | 4 | 1992 | 208 | 0.090 |
Why?
|
| Piperazines | 1 | 2013 | 331 | 0.090 |
Why?
|
| Methylation | 1 | 2011 | 212 | 0.090 |
Why?
|
| U937 Cells | 2 | 2007 | 29 | 0.090 |
Why?
|
| Airway Remodeling | 1 | 2010 | 60 | 0.090 |
Why?
|
| Chromatin | 2 | 2021 | 448 | 0.090 |
Why?
|
| Peptides | 3 | 2006 | 884 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 523 | 0.090 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2004 | 103 | 0.090 |
Why?
|
| Neprilysin | 1 | 2010 | 47 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 400 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2018 | 1214 | 0.090 |
Why?
|
| Cell Migration Inhibition | 5 | 2007 | 17 | 0.090 |
Why?
|
| Leukotriene B4 | 4 | 2004 | 57 | 0.080 |
Why?
|
| Antibody Formation | 1 | 2011 | 282 | 0.080 |
Why?
|
| Transfection | 5 | 2006 | 923 | 0.080 |
Why?
|
| Receptors, Adenosine A2 | 1 | 2009 | 6 | 0.080 |
Why?
|
| beta Catenin | 1 | 2011 | 231 | 0.080 |
Why?
|
| Obesity | 2 | 2021 | 2805 | 0.080 |
Why?
|
| ROC Curve | 1 | 2011 | 501 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2011 | 193 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2016 | 612 | 0.080 |
Why?
|
| Adenine | 1 | 2011 | 229 | 0.080 |
Why?
|
| Oxidative Phosphorylation | 1 | 2010 | 161 | 0.080 |
Why?
|
| Chemotactic Factors | 3 | 2007 | 51 | 0.080 |
Why?
|
| Immunophenotyping | 1 | 2010 | 286 | 0.080 |
Why?
|
| Killer Cells, Natural | 4 | 2004 | 389 | 0.080 |
Why?
|
| Gene Deletion | 3 | 2022 | 362 | 0.080 |
Why?
|
| CD47 Antigen | 3 | 1998 | 22 | 0.080 |
Why?
|
| Water | 1 | 2012 | 432 | 0.080 |
Why?
|
| Time Factors | 9 | 2008 | 6780 | 0.080 |
Why?
|
| Nylons | 1 | 2008 | 19 | 0.080 |
Why?
|
| Pyridines | 1 | 1992 | 445 | 0.080 |
Why?
|
| I-kappa B Proteins | 1 | 2009 | 82 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 532 | 0.080 |
Why?
|
| Biodiversity | 1 | 2012 | 382 | 0.080 |
Why?
|
| Phenotype | 4 | 2016 | 3153 | 0.080 |
Why?
|
| Biotinylation | 2 | 2005 | 32 | 0.080 |
Why?
|
| Yersinia Infections | 1 | 2007 | 4 | 0.080 |
Why?
|
| Peyer's Patches | 1 | 2007 | 8 | 0.080 |
Why?
|
| Methacrylates | 1 | 2008 | 111 | 0.080 |
Why?
|
| Siderophores | 1 | 2007 | 8 | 0.080 |
Why?
|
| Sepharose | 2 | 2007 | 33 | 0.080 |
Why?
|
| Enterobacteriaceae | 1 | 2007 | 33 | 0.070 |
Why?
|
| Drug Carriers | 1 | 2008 | 119 | 0.070 |
Why?
|
| CD11c Antigen | 1 | 2007 | 38 | 0.070 |
Why?
|
| CD11b Antigen | 1 | 2007 | 58 | 0.070 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 2 | 2009 | 9 | 0.070 |
Why?
|
| COP9 Signalosome Complex | 1 | 2007 | 6 | 0.070 |
Why?
|
| Gastrointestinal Agents | 1 | 2007 | 60 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 4 | 2006 | 1300 | 0.070 |
Why?
|
| Adoptive Transfer | 2 | 2021 | 205 | 0.070 |
Why?
|
| beta 2-Microglobulin | 2 | 1999 | 47 | 0.070 |
Why?
|
| Escherichia coli | 3 | 2022 | 766 | 0.070 |
Why?
|
| Eosinophilia | 1 | 2009 | 185 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 309 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2011 | 516 | 0.070 |
Why?
|
| Myocardium | 1 | 2012 | 992 | 0.070 |
Why?
|
| Multigene Family | 1 | 2007 | 205 | 0.070 |
Why?
|
| Dexamethasone | 1 | 2008 | 329 | 0.070 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 2 | 1996 | 25 | 0.070 |
Why?
|
| Solute Carrier Family 12, Member 1 | 1 | 2006 | 2 | 0.070 |
Why?
|
| Complement C5 | 1 | 2006 | 76 | 0.070 |
Why?
|
| Colforsin | 2 | 1996 | 62 | 0.070 |
Why?
|
| Cervix Uteri | 1 | 2006 | 49 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2017 | 2333 | 0.070 |
Why?
|
| Peptide Hydrolases | 1 | 2007 | 110 | 0.070 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 87 | 0.070 |
Why?
|
| Sp Transcription Factors | 1 | 2005 | 2 | 0.070 |
Why?
|
| Enterococcus faecalis | 3 | 1992 | 25 | 0.070 |
Why?
|
| Biological Transport, Active | 1 | 2005 | 74 | 0.070 |
Why?
|
| Blood Bactericidal Activity | 1 | 2005 | 37 | 0.070 |
Why?
|
| Eicosanoids | 2 | 2003 | 56 | 0.070 |
Why?
|
| Cattle | 3 | 2003 | 1010 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 34 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 1992 | 0.060 |
Why?
|
| Receptors, Formyl Peptide | 2 | 2003 | 11 | 0.060 |
Why?
|
| Consensus Sequence | 1 | 2005 | 71 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 371 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 2009 | 0.060 |
Why?
|
| Electric Impedance | 2 | 2017 | 105 | 0.060 |
Why?
|
| Triazines | 1 | 2004 | 39 | 0.060 |
Why?
|
| Lymphocytes | 2 | 1997 | 356 | 0.060 |
Why?
|
| Diet | 1 | 2012 | 1178 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2005 | 344 | 0.060 |
Why?
|
| Diacylglycerol Kinase | 1 | 2004 | 5 | 0.060 |
Why?
|
| Intracellular Fluid | 1 | 2004 | 27 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2005 | 220 | 0.060 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2003 | 16 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 3 | 2012 | 457 | 0.060 |
Why?
|
| HSP110 Heat-Shock Proteins | 1 | 2003 | 1 | 0.060 |
Why?
|
| Diglycerides | 1 | 2004 | 56 | 0.060 |
Why?
|
| Paneth Cells | 1 | 2023 | 18 | 0.060 |
Why?
|
| Hepatic Stellate Cells | 1 | 2023 | 11 | 0.060 |
Why?
|
| Triazoles | 1 | 2004 | 134 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2002 | 317 | 0.060 |
Why?
|
| Mice, Mutant Strains | 3 | 2010 | 289 | 0.050 |
Why?
|
| Culture Media, Conditioned | 3 | 1998 | 112 | 0.050 |
Why?
|
| Interleukin-17 | 1 | 2023 | 106 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2003 | 186 | 0.050 |
Why?
|
| HLA Antigens | 2 | 1994 | 235 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 2848 | 0.050 |
Why?
|
| Diterpenes | 1 | 2002 | 34 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2006 | 310 | 0.050 |
Why?
|
| Necrosis | 1 | 2023 | 234 | 0.050 |
Why?
|
| NADH Dehydrogenase | 1 | 2022 | 18 | 0.050 |
Why?
|
| Precipitin Tests | 5 | 2003 | 96 | 0.050 |
Why?
|
| Nucleosides | 1 | 2022 | 26 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 138 | 0.050 |
Why?
|
| Receptors, HIV | 1 | 2002 | 23 | 0.050 |
Why?
|
| Guanosine Triphosphate | 1 | 2022 | 94 | 0.050 |
Why?
|
| Chelating Agents | 1 | 2002 | 77 | 0.050 |
Why?
|
| Immunologic Surveillance | 1 | 2002 | 20 | 0.050 |
Why?
|
| Digestive System | 1 | 2002 | 31 | 0.050 |
Why?
|
| Macrophages, Peritoneal | 1 | 2002 | 97 | 0.050 |
Why?
|
| Enzyme Induction | 1 | 2002 | 95 | 0.050 |
Why?
|
| Cell Survival | 3 | 2015 | 1081 | 0.050 |
Why?
|
| Urothelium | 1 | 2002 | 33 | 0.050 |
Why?
|
| Trefoil Factor-3 | 1 | 2001 | 5 | 0.050 |
Why?
|
| Integrin beta3 | 1 | 2001 | 10 | 0.050 |
Why?
|
| Syk Kinase | 1 | 2001 | 16 | 0.050 |
Why?
|
| Phosphotyrosine | 1 | 2001 | 37 | 0.050 |
Why?
|
| Skin | 2 | 2003 | 698 | 0.050 |
Why?
|
| Stereoisomerism | 3 | 2007 | 102 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 1347 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2022 | 310 | 0.050 |
Why?
|
| Germ-Free Life | 1 | 2021 | 30 | 0.050 |
Why?
|
| Colorado | 1 | 2011 | 4471 | 0.050 |
Why?
|
| Chemotaxis | 2 | 2010 | 139 | 0.050 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2001 | 35 | 0.050 |
Why?
|
| Androstadienes | 1 | 2001 | 94 | 0.050 |
Why?
|
| A549 Cells | 1 | 2021 | 61 | 0.050 |
Why?
|
| Gain of Function Mutation | 1 | 2021 | 32 | 0.050 |
Why?
|
| Endpoint Determination | 1 | 2021 | 67 | 0.050 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2020 | 22 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2021 | 52 | 0.050 |
Why?
|
| Dermis | 1 | 2000 | 30 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2002 | 470 | 0.050 |
Why?
|
| Pseudomonas Infections | 1 | 2002 | 192 | 0.040 |
Why?
|
| Protein Transport | 1 | 2002 | 419 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2003 | 861 | 0.040 |
Why?
|
| Inactivation, Metabolic | 1 | 2020 | 11 | 0.040 |
Why?
|
| Electrophysiology | 2 | 1998 | 205 | 0.040 |
Why?
|
| Homozygote | 2 | 1992 | 195 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 214 | 0.040 |
Why?
|
| HT29 Cells | 1 | 1999 | 37 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 304 | 0.040 |
Why?
|
| Intestine, Small | 2 | 1999 | 135 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1996 | 2026 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 163 | 0.040 |
Why?
|
| Heterozygote | 2 | 1992 | 271 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2020 | 143 | 0.040 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2000 | 125 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2019 | 100 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2019 | 143 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2020 | 88 | 0.040 |
Why?
|
| Mice, Inbred Strains | 3 | 2006 | 423 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 1999 | 184 | 0.040 |
Why?
|
| Carbachol | 1 | 1998 | 23 | 0.040 |
Why?
|
| Receptors, Interleukin | 2 | 1998 | 41 | 0.040 |
Why?
|
| Receptors, Complement 3b | 1 | 1999 | 83 | 0.040 |
Why?
|
| Horses | 2 | 1989 | 110 | 0.040 |
Why?
|
| Lysosomes | 1 | 2019 | 136 | 0.040 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1998 | 17 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2002 | 593 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2000 | 863 | 0.040 |
Why?
|
| Prostaglandins | 1 | 1998 | 85 | 0.040 |
Why?
|
| Ribosomes | 1 | 2019 | 147 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2003 | 1450 | 0.040 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2020 | 127 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 2021 | 293 | 0.040 |
Why?
|
| Thalidomide | 1 | 1998 | 29 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2002 | 713 | 0.040 |
Why?
|
| Nucleotidases | 1 | 2017 | 7 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2021 | 607 | 0.040 |
Why?
|
| Nitrates | 1 | 1998 | 79 | 0.040 |
Why?
|
| Cyclic GMP | 1 | 1998 | 111 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 413 | 0.040 |
Why?
|
| Epoprostenol | 1 | 1998 | 139 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1999 | 356 | 0.040 |
Why?
|
| NAD | 1 | 1998 | 73 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 1998 | 148 | 0.040 |
Why?
|
| Bacterial Adhesion | 2 | 1998 | 80 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2017 | 69 | 0.040 |
Why?
|
| Weight Loss | 1 | 2022 | 677 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 333 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2019 | 349 | 0.040 |
Why?
|
| CD3 Complex | 1 | 1997 | 94 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2017 | 79 | 0.040 |
Why?
|
| Receptors, CXCR4 | 1 | 2017 | 81 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 3 | 2007 | 1233 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2018 | 251 | 0.030 |
Why?
|
| Anemia | 2 | 2016 | 162 | 0.030 |
Why?
|
| Thionucleotides | 1 | 1996 | 34 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 557 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1996 | 31 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1997 | 176 | 0.030 |
Why?
|
| Integrin beta Chains | 1 | 2016 | 7 | 0.030 |
Why?
|
| Leukosialin | 1 | 2016 | 15 | 0.030 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2016 | 27 | 0.030 |
Why?
|
| Complement C3 | 1 | 1997 | 193 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 74 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1996 | 118 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2016 | 79 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1993 | 158 | 0.030 |
Why?
|
| Ligands | 3 | 2008 | 574 | 0.030 |
Why?
|
| Bevacizumab | 1 | 2016 | 127 | 0.030 |
Why?
|
| Neuraminidase | 1 | 1995 | 26 | 0.030 |
Why?
|
| L-Selectin | 1 | 1995 | 27 | 0.030 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2016 | 88 | 0.030 |
Why?
|
| Antibodies | 1 | 1997 | 396 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 1995 | 66 | 0.030 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1995 | 6 | 0.030 |
Why?
|
| Botulinum Toxins | 1 | 1995 | 40 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2015 | 36 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 2016 | 141 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2015 | 124 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 1996 | 183 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 2016 | 100 | 0.030 |
Why?
|
| Gonadotrophs | 1 | 2015 | 21 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1995 | 159 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 334 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2015 | 58 | 0.030 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2016 | 88 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1996 | 341 | 0.030 |
Why?
|
| Receptors, Interleukin-4 | 1 | 1994 | 15 | 0.030 |
Why?
|
| Receptors, Mitogen | 1 | 1994 | 8 | 0.030 |
Why?
|
| Immunoblotting | 2 | 2011 | 313 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2015 | 100 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2015 | 102 | 0.030 |
Why?
|
| Complement Activation | 1 | 1997 | 350 | 0.030 |
Why?
|
| Cadherins | 2 | 2011 | 190 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 249 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2013 | 8 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 1995 | 91 | 0.030 |
Why?
|
| Rats | 2 | 2017 | 5517 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 18 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 169 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2013 | 39 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 292 | 0.030 |
Why?
|
| Proteomics | 1 | 2019 | 903 | 0.030 |
Why?
|
| Pituitary Neoplasms | 1 | 2015 | 165 | 0.030 |
Why?
|
| Aorta | 1 | 1996 | 417 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 1997 | 1077 | 0.030 |
Why?
|
| Fatty Liver | 1 | 2016 | 256 | 0.030 |
Why?
|
| Apoptosis | 2 | 2015 | 2553 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 361 | 0.030 |
Why?
|
| Ribonucleotides | 1 | 1993 | 27 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2013 | 59 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2013 | 1684 | 0.030 |
Why?
|
| Esters | 2 | 2003 | 61 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 2135 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 77 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2013 | 109 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 437 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 1992 | 139 | 0.030 |
Why?
|
| Platelet Count | 1 | 1992 | 89 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2013 | 128 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2012 | 136 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 836 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 1992 | 120 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2016 | 335 | 0.030 |
Why?
|
| Zymosan | 1 | 1992 | 64 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1993 | 533 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2016 | 360 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 1992 | 315 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 2382 | 0.020 |
Why?
|
| Health | 1 | 2012 | 80 | 0.020 |
Why?
|
| Platelet Storage Pool Deficiency | 1 | 1991 | 2 | 0.020 |
Why?
|
| Phagocytes | 1 | 1992 | 92 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2013 | 170 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2015 | 429 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1991 | 60 | 0.020 |
Why?
|
| Cell Degranulation | 2 | 2003 | 38 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 1991 | 73 | 0.020 |
Why?
|
| Mycoplasma Infections | 1 | 1990 | 14 | 0.020 |
Why?
|
| Camelids, New World | 1 | 1990 | 5 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2017 | 660 | 0.020 |
Why?
|
| Chromatography, Liquid | 2 | 2006 | 363 | 0.020 |
Why?
|
| Phagocytosis | 1 | 1992 | 364 | 0.020 |
Why?
|
| Furans | 1 | 2010 | 24 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 420 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5348 | 0.020 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2010 | 12 | 0.020 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2010 | 20 | 0.020 |
Why?
|
| Acetamides | 1 | 2010 | 28 | 0.020 |
Why?
|
| Thiophenes | 1 | 2010 | 107 | 0.020 |
Why?
|
| Adolescent | 3 | 2019 | 19411 | 0.020 |
Why?
|
| Amino Acids, Dicarboxylic | 1 | 2009 | 11 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2010 | 86 | 0.020 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2009 | 8 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 476 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2009 | 52 | 0.020 |
Why?
|
| Eosinophil Cationic Protein | 1 | 2009 | 8 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2009 | 61 | 0.020 |
Why?
|
| Mass Spectrometry | 2 | 2006 | 699 | 0.020 |
Why?
|
| Luciferases | 1 | 2009 | 154 | 0.020 |
Why?
|
| Child | 2 | 2019 | 20014 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 1991 | 224 | 0.020 |
Why?
|
| Solute Carrier Family 12, Member 2 | 1 | 2008 | 7 | 0.020 |
Why?
|
| Insulin | 1 | 2018 | 2219 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2009 | 205 | 0.020 |
Why?
|
| Guinea Pigs | 2 | 2002 | 159 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2010 | 667 | 0.020 |
Why?
|
| Enterobacter aerogenes | 1 | 2007 | 1 | 0.020 |
Why?
|
| Yersinia enterocolitica | 1 | 2007 | 6 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 1635 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2004 | 406 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 1999 | 318 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2007 | 80 | 0.020 |
Why?
|
| Molecular Weight | 2 | 2000 | 345 | 0.020 |
Why?
|
| Phenols | 1 | 2007 | 87 | 0.020 |
Why?
|
| Thiazoles | 1 | 2007 | 129 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 1257 | 0.020 |
Why?
|
| Interleukins | 1 | 2008 | 243 | 0.020 |
Why?
|
| Inosine | 1 | 2006 | 12 | 0.020 |
Why?
|
| Complement C3-C5 Convertases | 1 | 2006 | 19 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2006 | 33 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2006 | 41 | 0.020 |
Why?
|
| Brain Edema | 1 | 2006 | 65 | 0.020 |
Why?
|
| Drug Design | 2 | 1998 | 162 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1990 | 642 | 0.020 |
Why?
|
| Body Temperature | 1 | 2006 | 236 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2019 | 9938 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2006 | 409 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 20859 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 2004 | 65 | 0.010 |
Why?
|
| Abetalipoproteinemia | 1 | 2004 | 3 | 0.010 |
Why?
|
| Immunoglobulin G | 2 | 2001 | 808 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 1110 | 0.010 |
Why?
|
| Integrins | 2 | 1995 | 84 | 0.010 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2003 | 46 | 0.010 |
Why?
|
| Electric Conductivity | 2 | 1995 | 92 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 276 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 988 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2004 | 176 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2003 | 157 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2004 | 181 | 0.010 |
Why?
|
| Phthalic Anhydrides | 1 | 2002 | 1 | 0.010 |
Why?
|
| Croton Oil | 1 | 2002 | 2 | 0.010 |
Why?
|
| DNA | 1 | 2010 | 1406 | 0.010 |
Why?
|
| Carboxylic Acids | 1 | 2003 | 30 | 0.010 |
Why?
|
| Gene Products, tat | 1 | 2003 | 21 | 0.010 |
Why?
|
| Calcimycin | 1 | 2002 | 58 | 0.010 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2002 | 52 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2003 | 224 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2003 | 206 | 0.010 |
Why?
|
| Terpenes | 1 | 2002 | 23 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 2004 | 238 | 0.010 |
Why?
|
| Iloprost | 1 | 2002 | 46 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2002 | 128 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 205 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 795 | 0.010 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2002 | 19 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2002 | 16 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2004 | 249 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1743 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 959 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2002 | 67 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 119 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2001 | 10 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 2002 | 71 | 0.010 |
Why?
|
| Buffers | 1 | 2001 | 56 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 158 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 419 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 178 | 0.010 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2000 | 11 | 0.010 |
Why?
|
| Microsomes | 1 | 2000 | 24 | 0.010 |
Why?
|
| Indomethacin | 1 | 2000 | 77 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 1904 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 796 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2002 | 632 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1999 | 90 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1999 | 191 | 0.010 |
Why?
|
| Models, Immunological | 1 | 1999 | 97 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1998 | 24 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 1998 | 33 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 1998 | 22 | 0.010 |
Why?
|
| Receptors, Interleukin-8A | 1 | 1998 | 6 | 0.010 |
Why?
|
| Receptors, Peptide | 1 | 1998 | 24 | 0.010 |
Why?
|
| CD2 Antigens | 1 | 1997 | 6 | 0.010 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 1997 | 7 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2002 | 506 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 1999 | 354 | 0.010 |
Why?
|
| Membrane Cofactor Protein | 1 | 1997 | 13 | 0.010 |
Why?
|
| Dinoprostone | 1 | 1998 | 195 | 0.010 |
Why?
|
| Complement Inactivator Proteins | 1 | 1997 | 40 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1999 | 330 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1997 | 201 | 0.010 |
Why?
|
| Superoxides | 1 | 1998 | 225 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1998 | 213 | 0.010 |
Why?
|
| Nocodazole | 1 | 1996 | 18 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 2244 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1996 | 45 | 0.010 |
Why?
|
| Models, Structural | 1 | 1996 | 38 | 0.010 |
Why?
|
| Melanoma | 1 | 2003 | 714 | 0.010 |
Why?
|
| rhoC GTP-Binding Protein | 1 | 1995 | 5 | 0.010 |
Why?
|
| ADP Ribose Transferases | 1 | 1995 | 10 | 0.010 |
Why?
|
| Surface Properties | 1 | 1997 | 411 | 0.010 |
Why?
|
| Paclitaxel | 1 | 1996 | 200 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 11384 | 0.010 |
Why?
|
| Peptides, Cyclic | 1 | 1996 | 265 | 0.010 |
Why?
|
| CD8 Antigens | 1 | 1994 | 72 | 0.010 |
Why?
|
| Glycosylation | 1 | 1994 | 133 | 0.010 |
Why?
|
| Microtubules | 1 | 1996 | 246 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 340 | 0.010 |
Why?
|
| Endothelium | 1 | 1994 | 120 | 0.010 |
Why?
|
| Theophylline | 1 | 1993 | 61 | 0.010 |
Why?
|
| Epitopes | 1 | 1995 | 450 | 0.010 |
Why?
|
| Rubidium | 1 | 1992 | 13 | 0.010 |
Why?
|
| Iodine | 1 | 1992 | 22 | 0.010 |
Why?
|
| Mutation | 1 | 2003 | 3520 | 0.010 |
Why?
|
| Biological Factors | 1 | 1992 | 43 | 0.010 |
Why?
|
| Abscess | 1 | 1992 | 75 | 0.010 |
Why?
|
| Blood Protein Electrophoresis | 1 | 1990 | 7 | 0.010 |
Why?
|
| Mycoplasma | 1 | 1990 | 8 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1993 | 230 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1990 | 57 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1990 | 202 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 1990 | 97 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1989 | 40 | 0.010 |
Why?
|
| Gelatin | 1 | 1989 | 36 | 0.010 |
Why?
|
| Culture Media | 1 | 1989 | 164 | 0.010 |
Why?
|
| Cell Count | 1 | 1989 | 321 | 0.010 |
Why?
|
| Iron | 1 | 1990 | 236 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1993 | 777 | 0.000 |
Why?
|